A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease
Abstract Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. However, current treatments only manage symptoms and lack the ability to slow or prevent disease progression. We utilized a systems genetics approach to identify potential risk genes and repurposable drugs for...
Saved in:
| Main Authors: | Lijun Dou, Zhenxing Xu, Jielin Xu, Chengxi Zang, Chang Su, Andrew A. Pieper, James B. Leverenz, Fei Wang, Xiongwei Zhu, Jeffrey Cummings, Feixiong Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-00870-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feline and Canine Coronaviruses: Common Genetic and Pathobiological Features
by: Sophie Le Poder
Published: (2011-01-01) -
Pathobiology of Hodgkin Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2011-01-01) -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01) -
Role of Sphingolipids in the Pathobiology of Lung Inflammation
by: Riccardo Ghidoni, et al.
Published: (2015-01-01) -
PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA
by: Roberto Stasi, et al.
Published: (2009-11-01)